Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study)

Introduction: Little is known about sex differences in lenvatinib treatment safety and efficacy. Methods: Real-word retrospective Italian multicenter study enrolling patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib. Results: A total of 138 patients (64 femal...

Descripció completa

Dades bibliogràfiques

Autors principals:	Giulia Puliani, Marta Bianchini, Carlotta Giani, Laura Valerio, Alice Nervo, Giulia Sapuppo, Giorgio Grani, Cristina Dalmiglio, Simone De Leo, Rosa Lauretta, Marilda Mormando, Irene Terrenato, Stefania Zovato, Laura Fugazzola, Maria Grazia Castagna, Cosimo Durante, Gabriella Pellegriti, Emanuela Arvat, Rossella Elisei, Marialuisa Appetecchia
Format:	Artigo
Idioma:	Inglês
Publicat:	Bioscientifica 2025-04-01
Col·lecció:	European Thyroid Journal
Matèries:	lenvatinib sex gender efficacy safety radioiodine-refractory differentiated thyroid cancer
Accés en línia:	https://etj.bioscientifica.com/view/journals/etj/14/2/ETJ-24-0386.xml
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!